Showing 1011-1020 of 2993 results for "".
Dementia Insights: Antiamyloid Antibody Therapy in Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-antiamyloid-antibody-therapy-in-alzheimer-disease/31928/The saga continues for development of antiamyloid monoclonal antibodies, aducanumab, lecanemab, donanemab, and gantenerumab for Alzheimer disease.Muscle MRI for Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/muscle-mri-for-neuromuscular-disorders/31687/Using muscle MRI to diagnose neuromuscular conditions requires awareness of different patterns of muscle involvement.Neuromyelitis Optica Spectrum Disorders
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuromyelitis-optica-spectrum-disorders/30129/It is critical to maintain a high index of suspicion for these conditions when evaluating a patient with demyelination to avoid delays in treatment.Identifying Candidates for Deep Brain Stimulation for Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/identifying-candidates-for-deep-brain-stimulation-for-parkinsons-disease/30749/Appropriate patient selection, pre-operative assessments, and careful patient counseling are all essential components to successful DBS in PD.A Closer Look at Parkinson's Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/a-closer-look-at-parkinsons-therapies/30691/An update by Practical NeurologyNeuromuscular Notes: Autoantibody Evaluations for Peripheral Neuropathies
https://practicalneurology.com/diseases-diagnoses/headache-pain/neuromuscular-notes-autoantibody-evaluations-for-peripheral-neuropathies/31857/Phenotype and nerve conduction can guide the search for autoantibodies in peripheral neuropathy.Pay for Performance: Understanding and Preparing for MIPS
https://practicalneurology.com/columns/practice-management/pay-for-performance-understanding-and-preparing-for-mips/30418/As a new reimbursement model is set to unveil, physicians will have a tight window to prepare their practices to begin reporting in 2017.Board Re-Certification: Reform or Reboot
https://practicalneurology.com/columns/practice-management/board-re-certification-reform-or-reboot/30542/A neurologist has been leading the charge to reform MOC in neurology. He talked to Practical Neurology® about the issue.Rising Drug Prices and the Cost of Care: What Can Physicians Do?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/rising-drug-prices-and-the-cost-of-care-what-can-physicians-do/30327/The multiple sclerosis drug market offers a snapshot of a growing problem. Physicians should speak out on behalf of the specialty and their patients.Preferred Treatment: The Changing Economics of Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/preferred-treatment-the-changing-economics-of-multiple-sclerosis-care/30486/By deciding which drugs are “preferred,” insurance companies are reducing the practice of evidence-based medicine to a series of economic choices.